Wolff Stefani 4
4 · Nurix Therapeutics, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Wolff Stefani
EVP and COO
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-14+88,900→ 88,900 totalExercise: $10.83Exp: 2033-02-13→ Common Stock (88,900 underlying) - Award
Restricted Stock Units
2023-02-14+24,000→ 24,000 totalExercise: $0.00→ Common Stock (24,000 underlying)
Footnotes (4)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning March 14, 2023 until the option is fully vested on February 14, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.
- [F3]The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on April 30, 2023, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- [F4]RSUs do not expire; they either vest or are canceled prior to the vest date.